These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 9707304)
61. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. Felmingham D; Grüneberg RN J Antimicrob Chemother; 2000 Feb; 45(2):191-203. PubMed ID: 10660501 [TBL] [Abstract][Full Text] [Related]
62. Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis. Bootsma HJ; van Dijk H; Verhoef J; Fleer A; Mooi FR Antimicrob Agents Chemother; 1996 Apr; 40(4):966-72. PubMed ID: 8849261 [TBL] [Abstract][Full Text] [Related]
63. [Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012]. Zhao C; Zhang F; Wang Z; Cao B; Xu X; Sun H; Zhang R; Hu Y; Liu Z; Du Y; Chen R; Zhuo C; Su D; Liu Y; Hu B; Wang H Zhonghua Jie He He Hu Xi Za Zhi; 2015 Jan; 38(1):18-22. PubMed ID: 25791651 [TBL] [Abstract][Full Text] [Related]
64. Moraxella catarrhalis, a human respiratory tract pathogen. Murphy TF; Parameswaran GI Clin Infect Dis; 2009 Jul; 49(1):124-31. PubMed ID: 19480579 [TBL] [Abstract][Full Text] [Related]
65. Individual use of antibiotics and prevalence of beta-lactamase production among bacterial pathogens from middle ear fluid. Thrane N; Olesen C; Sørensen HT; Schønheyder HC J Antimicrob Chemother; 2001 Feb; 47(2):211-4. PubMed ID: 11157910 [TBL] [Abstract][Full Text] [Related]
66. Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity. Eliasson I; Kamme C J Antimicrob Chemother; 1985 Feb; 15(2):139-49. PubMed ID: 3872294 [TBL] [Abstract][Full Text] [Related]
67. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora. Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284 [TBL] [Abstract][Full Text] [Related]
68. The incidence of respiratory tract pathogens and antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated between 1990 and 1993. Nishioka K; Ogihara H; Ohno I; Tanno Y; Shirato K Tohoku J Exp Med; 1996 Jun; 179(2):111-21. PubMed ID: 8875767 [TBL] [Abstract][Full Text] [Related]
69. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905 [TBL] [Abstract][Full Text] [Related]
70. [Moraxella (Branhamella) catarrhalis. A common pathogenic agent]. Prost J; Scavizzi M Presse Med; 1993 May 1-8; 22(16):779-82. PubMed ID: 8316533 [TBL] [Abstract][Full Text] [Related]
71. In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs. Schmitz FJ; Boos M; Mayer S; Verhoef J; Milatovic D; Fluit AC J Antimicrob Chemother; 2002 Jan; 49(1):220-3. PubMed ID: 11751796 [No Abstract] [Full Text] [Related]
72. Isolation of Moraxella catarrhalis from sputum specimens of Malaysian patients. Ahmad N; Cheong YM; Tahir HM Malays J Pathol; 1994 Jun; 16(1):63-7. PubMed ID: 16329578 [TBL] [Abstract][Full Text] [Related]
73. A multicenter study of the antimicrobial susceptibility of Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal. Melo-Cristino J; Fernandes ML; Serrano N; Microb Drug Resist; 2001; 7(1):33-8. PubMed ID: 11310801 [TBL] [Abstract][Full Text] [Related]
74. Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. Hol C; Van Dijke EE; Verduin CM; Verhoef J; van Dijk H J Infect Dis; 1994 Dec; 170(6):1613-6. PubMed ID: 7996007 [TBL] [Abstract][Full Text] [Related]
75. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692 [TBL] [Abstract][Full Text] [Related]